CJC-1295 No DAC 5mg Research Peptide

Description

Buy CJC-1295 UK | CJC-1295 No DAC 5mg Research Peptide

Buy CJC-1295 UK from XL Peptides for controlled in-vitro laboratory research. Researchers looking to buy CJC-1295 No DAC UK can source our CJC-1295 research peptide as CJC-1295 5mg lyophilised material for experimental studies of GHRH receptor signalling, second-messenger pathways and GH-axis biology.

CJC-1295 No DAC is commonly referred to as Mod GRF(1–29). Researchers use this non-DAC GHRH analogue to investigate receptor engagement, cAMP-related signalling and structure–activity relationships under controlled experimental conditions.

However, laboratory and preclinical findings do not establish safety, efficacy or suitability for human use. Therefore, XL Peptides supplies this material strictly for laboratory research.

For laboratory research only. Not for human or veterinary use.

CJC-1295 No DAC 5mg key features

• Contains 5 mg of lyophilised research material.
• Non-DAC GHRH analogue commonly referred to as Mod GRF(1–29).
• Suitable for controlled in-vitro GHRH receptor-signalling studies.
• Relevant to experimental research into cAMP and GH-axis pathways.
• Intended strictly for laboratory research.

CJC-1295 No DAC 5mg product specifications

• Product name: CJC-1295 No DAC
• Product size: 5 mg
• Alternative name: Mod GRF(1–29)
• Synonyms: CJC-1295 No DAC; modified GRF(1–29); tetrasubstituted GRF(1–29)
• Class: GHRH analogue
• Research target: Growth hormone-releasing hormone receptor signalling
• Form: Lyophilised powder
• Appearance: White to off-white solid
• Intended use: Laboratory research only

Buy CJC-1295 UK — Handling & Storage

Correct laboratory handling helps maintain consistency between experiments. Therefore, keep unopened lyophilised vials cool, dry and protected from direct light and moisture.

1. Dry storage: Keep lyophilised material at 2–8 °C, protected from light and moisture.
2. Preparation: Allow the vial and an appropriate laboratory diluent to reach room temperature before preparation.
3. Mixing: Introduce laboratory diluent slowly down the side of the vial. Then swirl gently rather than shaking or vortexing.
4. Prepared material: Keep prepared research solutions at 2–8 °C where appropriate for the laboratory protocol.
5. Laboratory practice: Follow validated SOPs for concentration, solvent compatibility, contamination control and experimental use.

For additional information, see our
Peptide Reconstitution, Handling & Storage Guide.

Buy CJC-1295 No DAC UK for Laboratory Research

Researchers looking to buy CJC-1295 No DAC UK may use this peptide in controlled experimental investigations of GHRH receptor signalling, ligand–receptor interactions and downstream second-messenger pathways.

Additionally, laboratory models can examine cAMP-related signalling and downstream pathway responses following receptor activation. For example, researchers may compare signalling behaviour between GHRH analogues under defined experimental conditions.

Because these studies remain laboratory and preclinical research, they do not establish clinical effectiveness or human safety. Therefore, XL Peptides supplies CJC-1295 No DAC solely as a research material.

CJC-1295 research peptide studies

Researchers use the CJC-1295 research peptide in controlled experimental systems to investigate GHRH receptor pharmacology and GH-axis signalling.

Moreover, the non-DAC variant allows researchers to examine receptor activation and downstream signalling without the drug-affinity-complex modification associated with other CJC-1295 variants.

For example, experimental models may compare receptor responses, signalling kinetics and downstream molecular activity. In addition, researchers can investigate structure–activity relationships between modified GHRH analogues.

Therefore, these studies focus on molecular and cellular mechanisms rather than clinical outcomes.

Why Researchers Buy CJC-1295 UK

Researchers may select CJC-1295 5mg when investigating GHRH receptor signalling, second-messenger pathways and GH-axis biology under controlled laboratory conditions.

Additionally, the non-DAC form provides a defined GHRH analogue for receptor-pharmacology studies. Furthermore, its lyophilised format supports convenient laboratory handling and storage.

As a result, researchers sourcing CJC-1295 UK can obtain the material domestically for clearly defined research-use-only applications.

Related CJC-1295 research products

Researchers investigating GHRH, GHSR, GH-axis and related metabolic signalling pathways may also be interested in:

• Ipamorelin 5mg
• GHRP-6 5mg
• IGF-1 LR3 1mg — for broader IGF-axis signalling research
• SLU-PP-332 5mg — for broader metabolic and cellular-energy research

Frequently asked questions

What is CJC-1295 No DAC?
CJC-1295 No DAC is a modified GHRH analogue commonly referred to as Mod GRF(1–29). In particular, researchers use it to investigate GHRH receptor signalling and related GH-axis pathways.

Is CJC-1295 No DAC the same as Mod GRF(1–29)?
The terms are commonly used interchangeably in the research-peptide market for the non-DAC, modified GRF(1–29) peptide. Therefore, researchers searching for either term may encounter the same type of research material.

How much CJC-1295 does each vial contain?
Each vial contains CJC-1295 No DAC 5mg as lyophilised research material.

What do researchers study with CJC-1295 No DAC?
Researchers investigate GHRH receptor pharmacology, second-messenger signalling and GH-axis pathways. In addition, experimental models can examine receptor activation and structure–activity relationships.

How should laboratories store CJC-1295?
Keep unopened lyophilised material at 2–8 °C and protect it from light and moisture. After preparation, however, laboratories should follow their own SOPs and the requirements of the relevant experimental protocol.

Where can I find CJC-1295 handling information?
General laboratory handling and storage information is provided in the handling section above.

Where can researchers buy CJC-1295 in the UK?
Researchers can buy CJC-1295 from XL Peptides for controlled in-vitro laboratory research. Furthermore, each vial contains 5 mg of lyophilised CJC-1295 No DAC research material.

Is CJC-1295 No DAC intended for human use?
No. XL Peptides supplies CJC-1295 No DAC strictly for laboratory research. Therefore, it is not intended for human or veterinary use, consumption, administration, diagnosis, treatment or clinical applications.

CJC-1295 research papers & external resources

Legal & safety information

XL Peptides supplies this material strictly for laboratory research. Therefore, it is not a medication, food, supplement, cosmetic or consumer-use product and is not for human or veterinary use.

Additionally, customers confirm through purchase that appropriately qualified personnel will handle the material according to institutional procedures and applicable laws and regulations.

Disclaimer

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use